Organization
Department of Rheumatology, Rinku General Medical Center, Izumisano
1 abstract
Abstract
ABATACEPT TREATMENT SUPPRESSES T CELL ACTIVATION IN ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY (ACPA) POSITIVE RA PATIENTS BUT NOT IN ACPA NEGATIVE RA PATIENTS Org: Laboratory of Immune Regulation, Wakayama Medical University, Osaka Rheumatology Clinic, Osaka, Division of Rheumatology, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya city, Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Department of Rheumatology, Yukioka Hospital, Osaka, Department of Orthopaedic Surgery and Rheumatology, Nara Hospital, Kinki University School of Medicine, Ikoma, Department of Orthopaedic Surgery, Tokyo Women's Medical University Daini Hospital, Division of Rheumatic Disease, Tokyo Metropolitan Otsuka Hospital, Tokyo, Department of Pharmacology, Hamamatsu University School of Medicine, Hamamatsu, Department of Orthopaedic Surgery, Kinki University School of Medicine, Osakasayama, Japan,